EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sphingolipids in Extracellular Vesicles Released From the Skeletal Muscle Plasma Membrane Control Muscle Stem Cell Fate During Muscle Regeneration

Rhyma Hakkar, Caroline E Brun iD, Pascal Leblanc iD, Emmanuelle Meugnier iD, Emmanuelle Berger-Danty iD, Olivier Blanc-Brude iD, Stefano Tacconi iD, Audrey Jalabert, Laura Reininger, Sandra Pesenti, Catherine Calzada iD, Vincent Gache iD und 12 weitere

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2025. Verfasst von Rhyma Hakkar und 23 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cardiology, Metabolism, Nutrition and Diabetes (CarMeN), UMR INSERM 1060-INRAE 1397, University of Lyon, Pierre Benite, France. Hauptthemen laut MEDLINE: Extracellular Vesicles, Muscle, Skeletal, Regeneration, Sphingolipids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) represent a cytokine‐independent pathway though which skeletal muscle (SkM) cells influence the fate of neighbouring cells, thereby regulating SkM metabolic homeostasis and regeneration. Although SkM‐EVs are increasingly being explored as a therapeutic strategy to enhance muscle regeneration or to induce the myogenic differentiation of induced pluripotent stem cells (iPSCs), the mechanisms governing their release from muscle cells remain poorly described. Moreover, because muscle regeneration involves a tightly regulated inflammatory response it also important to determine how inflammation alters SkM‐EV cargo and function in order to design more effective EV‐based therapies. To address this knowledge gap, we isolated and characterized the large and small EVs (lEVs, sEVs) released from SkM cells under basal conditions and in response to TNF‐α, a well‐established inflammatory mediator elevated in both acute muscle injury and chronic inflammatory conditions such as type 2 diabetes. We then evaluated the regenerative roles of these EV subtypes in vivo using a mouse model of cardiotoxin‐induced muscle injury, with a specific focus on their bioactive sphingolipid content. Using transmission, scanning or cryo‐electron microscopy, lipidomic profiling and an adenoviral construct to express labelled CD63 in myotubes, we demonstrated that SkM cells release both sEVs and lEVs primarily from the plasma membrane. Notably, sEVs were generated from specialized membrane folds enriched in the EV markers ALIX (ALG‐2 interacting protein X) and TSG101, as well as lipid raft‐associated lipids. During regeneration, sEVs promoted M1 macrophage polarization and migration and muscle stem cell (MuSC) differentiation, thereby accelerating muscle repair. In contrast, lEVs inhibited and promoted MuSC proliferation and impaired the transition from the pro‐inflammatory to the anti‐inflammatory response, an essential step for promoting MuSC differentiation. Treatment of isolated muscle fibres with SkM‐EVs revealed that the distinct effects of sEVs and lEVs on MuSC behaviour and macrophage phenotype could be largely explained by differences in their lipid composition, particularly the ratio of sphingosine‐1‐phosphate (S1P) subspecies. However, TNF‐α exposure altered these ratios in sEVs and impaired their regenerative functions on MuSC and their effect on macrophage migration and polarization. These results demonstrate for the first time the importance of the sphingolipid content of EVs released by skeletal muscle in their regenerative function within muscle tissue, largely explained by their role as carriers of different subspecies of sphingosine‐1‐phosphate. This suggests that modulating the sphingolipid composition of EVs could be a viable strategy to enhance the regenerative potential of muscle tissue in addition to therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMuscle, SkeletalRegenerationSphingolipidsCell MembraneStem CellsAnimalsMiceCell DifferentiationMice, Inbred C57BLMale

Stichwörter der Autor:innen

extracellular vesicleslipidomicmuscle stem cellsregenerationskeletal musclesphingosine‐1‐phosphate

Substanzen

Sphingolipids

Autor:innen und Institutionen

  • Laboratory of Cardiology, Metabolism, Nutrition and Diabetes (CarMeN), UMR INSERM 1060-INRAE 1397, University of Lyon, Pierre Benite, France.
  • Institut NeuroMyoGène, Laboratoire Physiopathologie et Génétique du Neurone et du Muscle, UMR INSERM 1315-CNRS 5261, University Claude Bernard Lyon 1, Lyon, France, Lyon, France.
  • Laboratoire Ecologie Microbienne, UMR CNRS 5557-INRAE 1418, VetAgroSup, Université of Lyon, Villeurbanne, France.
  • Université Paris Cité, INSERM, UMR S970, PARCC, Paris, France.
  • Unité de recherche CEED DIATHEC UR 7294 Université de Strasbourg, Strasbourg, France.
  • Oniris, INRAE, PAnTher, Nantes, France.

ORCID-Profile: Caroline E Brun, Pascal Leblanc, Emmanuelle Meugnier, Emmanuelle Berger-Danty, Olivier Blanc-Brude, Stefano Tacconi, Catherine Calzada, Vincent Gache, Bong Hwan Sung, Alissa Weaver, Antonella Bongiovanni, Karl Rouger, Jean-Paul Pais de Barros, Karim Bouzakri, Sophie Rome

Förderung

  • NCI NIH HHS
  • Agence Nationale de la Recherche

Zitieren

APA

Hakkar, R., Brun, C. E., Leblanc, P., Meugnier, E., Berger-Danty, E., Blanc-Brude, O., Tacconi, S., Jalabert, A., Reininger, L., Pesenti, S., Calzada, C., Gache, V., Vasan, S. B., Pichon, J., Larcher, T., Errazuriz-Cerda, E., Cassin, C., Sung, B. H., Weaver, A., …, & Rome, S. (2025). Sphingolipids in Extracellular Vesicles Released From the Skeletal Muscle Plasma Membrane Control Muscle Stem Cell Fate During Muscle Regeneration. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70164

Vancouver

Hakkar R, Brun CE, Leblanc P, Meugnier E, Berger-Danty E, Blanc-Brude O, et al. Sphingolipids in Extracellular Vesicles Released From the Skeletal Muscle Plasma Membrane Control Muscle Stem Cell Fate During Muscle Regeneration. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70164

BibTeX
@article{Hakkar2025,
  author = {Hakkar, Rhyma and Brun, Caroline E and Leblanc, Pascal and Meugnier, Emmanuelle and Berger-Danty, Emmanuelle and Blanc-Brude, Olivier and Tacconi, Stefano and Jalabert, Audrey and Reininger, Laura and Pesenti, Sandra and Calzada, Catherine and Gache, Vincent and Vasan, Sanjay B and Pichon, Julien and Larcher, Thibaut and Errazuriz-Cerda, Elizabeth and Cassin, Christelle and Sung, Bong Hwan and Weaver, Alissa and Bongiovanni, Antonella and Rouger, Karl and de Barros, Jean-Paul Pais and Bouzakri, Karim and Rome, Sophie},
  title = {Sphingolipids in Extracellular Vesicles Released From the Skeletal Muscle Plasma Membrane Control Muscle Stem Cell Fate During Muscle Regeneration},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70164}
}
Kostenlos starten →